Preclinical efficacy of prexasertib in acute lymphoblastic leukemia

Jason Ostergaard, Leslie M. Jonart, Maryam Ebadi, Stacia L. Koppenhafer, David J. Gordon, Peter M. Gordon

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1094-1098
Number of pages5
JournalBritish journal of haematology
Volume194
Issue number6
Early online dateJun 7 2021
DOIs
StatePublished - Sep 2021

Bibliographical note

Funding Information:
This work was supported in part by the Timothy O’Connell Foundation and the Children's Cancer Research Fund (P.M.G). Contributions: J.O. designed and performed experiments, analysed data, and prepared figures. L.J., M.E., S.L.K. and D.J.G performed experiments and analysed data. P.M.G. designed the study, oversaw the laboratory investigations, and wrote the manuscript. All authors reviewed, edited and approved the final version of the manuscript.

Funding Information:
This work was supported in part by the Timothy O?Connell Foundation and the Children's Cancer Research Fund (P.M.G). Contributions: J.O. designed and performed experiments, analysed data, and prepared figures. L.J., M.E., S.L.K. and D.J.G performed experiments and analysed data. P.M.G. designed the study, oversaw the laboratory investigations, and wrote the manuscript. All authors reviewed, edited and approved the final version of the manuscript.

Cite this